🇺🇸 FDA
Patent

US 8048851

Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response

granted A61KA61K38/00A61P

Quick answer

US patent 8048851 (Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response) held by The Regents of the University of California expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P25/28, A61P31/04